Predict your next investment

Intarcia Therapeutics company logo
Corporation
HEALTHCARE | Pharmaceuticals / Drugs
intarcia.com

See what CB Insights has to offer

Competitors

92

Business Relationships

5

Service Providers

3

Intarcia Therapeutics Competitors & Alternatives

92 Competitors

Intarcia Therapeutics has 92 competitors. Intarcia Therapeutics's competitors are Adamas Pharmaceuticals, Diasome Pharmaceuticals, CoImmune, Annovis Bio, Embera NeuroTherapeutics and more.

Latest Funding

Companies

Investment Stage

Total Funding

Mosaic
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

Location

10/11/2021

Acq - Pending

$71.67M

California

12/23/2020

Debt - III

$64.07M

Ohio

11/10/2020

Unattributed VC

$240.07M

North Carolina

1/29/2020

IPO

$11.88M

Pennsylvania

12/19/2019

Grant - V

$43.48M

Massachusetts

3/8/2019

Loan

$81.48M

Ireland

2/6/2019

Debt - II

$55.9M

Michigan

12/19/2018

PIPE

California

12/18/2018

PIPE

Canada

Latest Funding

10/11/2021

12/23/2020

11/10/2020

1/29/2020

12/19/2019

3/8/2019

2/6/2019

12/19/2018

12/18/2018

Companies

Investment Stage

Acq - Pending

Debt - III

Unattributed VC

IPO

Grant - V

Loan

Debt - II

PIPE

PIPE

Total Funding

$71.67M

$64.07M

$240.07M

$11.88M

$43.48M

$81.48M

$55.9M

Mosaic

Location

California

Ohio

North Carolina

Pennsylvania

Massachusetts

Ireland

Michigan

California

Canada

Intarcia Therapeutics Service Providers

5 Service Providers

Intarcia Therapeutics has 5 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Debt - V

Commercial Bank

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Subscribe to see more

Associated Rounds

Debt - V

Subscribe to see more

Subscribe to see more

Provider Type

Commercial Bank

Subscribe to see more

Subscribe to see more

Service Type

Subscribe to see more

Subscribe to see more

Partnership data by VentureSource

Intarcia Therapeutics Partners & Customers

5 Partners and customers

Intarcia Therapeutics has 5 strategic partners and customers. Intarcia Therapeutics recently partnered with Numab Therapeutics on March 3, 2019.

Date

Type

Business Partner

Country

News Snippet

Sources

3/5/2019

Licensor

Numab Therapeutics

Switzerland

Numab Announces Entry into a License Agreement With Intarcia for Anti-Inflammatory ND016

Founded in 2011 , Numab develops a proprietary pipeline of multi-specific biotherapeutics in immuno-oncology and immunology , and has partnerships with Intarcia Therapeutics , Ono Pharmaceutical , Kaken Pharmaceutical , and Tillotts Pharma .

2

9/14/2017

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

1/1/2017

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

12/29/2016

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

11/12/2014

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

3/5/2019

9/14/2017

1/1/2017

12/29/2016

11/12/2014

Type

Licensor

Partner

Partner

Partner

Partner

Business Partner

Numab Therapeutics

Country

Switzerland

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

News Snippet

Numab Announces Entry into a License Agreement With Intarcia for Anti-Inflammatory ND016

Founded in 2011 , Numab develops a proprietary pipeline of multi-specific biotherapeutics in immuno-oncology and immunology , and has partnerships with Intarcia Therapeutics , Ono Pharmaceutical , Kaken Pharmaceutical , and Tillotts Pharma .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.